[go: up one dir, main page]

GB201312226D0 - Improved antibodies - Google Patents

Improved antibodies

Info

Publication number
GB201312226D0
GB201312226D0 GBGB1312226.2A GB201312226A GB201312226D0 GB 201312226 D0 GB201312226 D0 GB 201312226D0 GB 201312226 A GB201312226 A GB 201312226A GB 201312226 D0 GB201312226 D0 GB 201312226D0
Authority
GB
United Kingdom
Prior art keywords
improved antibodies
antibodies
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1312226.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADX NEUROSCIENCES
Katholieke Universiteit Leuven
Original Assignee
ADX NEUROSCIENCES
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADX NEUROSCIENCES, Katholieke Universiteit Leuven filed Critical ADX NEUROSCIENCES
Priority to GBGB1312226.2A priority Critical patent/GB201312226D0/en
Publication of GB201312226D0 publication Critical patent/GB201312226D0/en
Priority to PCT/EP2014/064658 priority patent/WO2015004163A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
GBGB1312226.2A 2013-07-08 2013-07-08 Improved antibodies Ceased GB201312226D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1312226.2A GB201312226D0 (en) 2013-07-08 2013-07-08 Improved antibodies
PCT/EP2014/064658 WO2015004163A1 (fr) 2013-07-08 2014-07-08 Anticorps monoclonaux anti-tau

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1312226.2A GB201312226D0 (en) 2013-07-08 2013-07-08 Improved antibodies

Publications (1)

Publication Number Publication Date
GB201312226D0 true GB201312226D0 (en) 2013-08-21

Family

ID=49033489

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1312226.2A Ceased GB201312226D0 (en) 2013-07-08 2013-07-08 Improved antibodies

Country Status (2)

Country Link
GB (1) GB201312226D0 (fr)
WO (1) WO2015004163A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20210522T1 (hr) * 2016-07-12 2021-05-14 H. Lundbeck A/S Antitijela specifična za hiperfosforilirani tau i načini njihove uporabe
MX2019009817A (es) * 2017-02-17 2019-11-21 Denali Therapeutics Inc Anticuerpos anti-tau y metodos de uso de los mismos.
CA3077247A1 (fr) 2017-10-16 2019-04-25 Eisai R & D Management Co., Ltd. Anticorps anti-tau et leurs utilisations
GB202010652D0 (en) * 2020-07-10 2020-08-26 Wista Lab Ltd Anti-tau antibodies
CL2021001380A1 (es) 2021-05-26 2022-01-14 Corporacion Centro Int De Biomedicina Icc Generación de un nuevo anticuerpo monoclonal sitio específico para la proteína tau y su uso como herramienta en biomarcadores específicos para la detección temprana de enfermedades neurodegenerativas y patologías involucradas con la proteína tau como alzheimer y otras demencias.
US20250134952A1 (en) 2021-09-20 2025-05-01 Institut National de la Santé et de la Recherche Médicale Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
WO2024133723A1 (fr) 2022-12-22 2024-06-27 Institut National de la Santé et de la Recherche Médicale Méthodes permettant de diminuer la résistance thérapeutique acquise à la chimiothérapie et/ou à la radiothérapie

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797478B1 (en) * 1998-03-05 2004-09-28 University Of Cincinnati Method of detecting axonal damage, from associated disease states using tau monoclonal antibodies
SI2625198T1 (sl) * 2010-10-07 2015-11-30 Ac Immune S.A. Epfl Innovation Park Protitelesa, ki prepoznavajo fosfo-tau
NZ609984A (en) * 2010-10-11 2015-05-29 Biogen Idec Internat Neuroscience Gmbh Human anti-tau antibodies

Also Published As

Publication number Publication date
WO2015004163A1 (fr) 2015-01-15

Similar Documents

Publication Publication Date Title
ZA201808451B (en) Anti-fcrh5 antibodies
GB201322583D0 (en) Antibodies
SG11201509361TA (en) Novel antibodies
ZA201603218B (en) Afucosylated anti-fgfr2iiib antibodies
ZA201601437B (en) Antibodies
ZA201506568B (en) Anti-tnf-anti-il-17 bispecific antibodies
GB201308658D0 (en) Antibodies
GB201315486D0 (en) Antibodies
GB201300706D0 (en) Antibody
IL245488B (en) Anti- ccl17 antibodies
GB201312226D0 (en) Improved antibodies
PL3016977T3 (pl) Ludzkie przeciwciała anty-IL-32
GB201318283D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)